VFA
GBT

Valeo Financial Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Valeo Financial Advisors’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed – – 2244
2020
Q2 		$0 Buy
+1
New +$69 ﹤0.01% 2199

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valeo Financial Advisors's GBT Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 1 share.

Valeo Financial Advisors first reported a position in GBT in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 1 Global Blood Therapeutics, Inc. share in Q3 2020.
  • Valeo Financial Advisors first reported a position in Global Blood Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Valeo Financial Advisors's Global Blood Therapeutics, Inc. position peaked at $0 in Q2 2020.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.